Watchlist Price Alert

Galectin Therapeutics Inc... (GALT)

NASDAQ: GALT · Real-Time Price · USD

3.29

0.90 (37.66%)

At close: Jun 18, 2025, 3:59 PM

Galectin Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	-45.19M	-47.05M	-45.08M	-44.28M	-41.03M	-41.07M	-41.7M	-39.87M	-40.37M	-38.78M	-35.36M	-35.29M	-34.12M	-30.53M	-31.16M	-28.58M	-26.25M	-23.46M	-20.75M	-17.59M	-14.47M	-13.29M	-11.21M	-11.18M	-12.02M	-13.9M	-13.23M	-14.89M	-15.56M	-16.23M	-18.44M	-18.56M	-19.57M	-21.44M	-21.52M	-22.88M	-22M
Depreciation & Amortization	38K	37K	36K	35K	10K	33K	32K	31K	54K	32K	35K	38K	41K	41K	39K	39K	37K	36K	36K	34K	34K	35K	27K	19K	11K	1K	n/a	n/a	n/a	1K	3K	5K	7K	7K	6K	6K	6K
Stock-Based Compensation	2.31M	2.45M	2.35M	2.42M	2.2M	2.26M	2.44M	2.54M	2.67M	2.87M	2.84M	2.75M	2.68M	2.08M	1.99M	1.81M	1.62M	1.8M	1.65M	1.65M	1.7M	1.68M	2.42M	2.67M	3.67M	4.45M	3.56M	3.13M	1.96M	1.1M	1.31M	1.45M	1.59M	2.48M	2.87M	3.29M	3.69M
Other Working Capital	1.41M	2.4M	1.41M	2.98M	2.5M	2.01M	1.65M	1.23M	916K	724K	360K	288K	141K	123K	286K	-1.08M	-1.18M	-1.29M	-662K	782K	775K	465K	339K	294K	-673K	-455K	-1.26M	-643K	-640K	-642K	-396K	-738K	534K	584K	876K	180K	530K
Other Non-Cash Items	1.39M	2.47M	4.08M	1.75M	1.78M	1.62M	1.62M	1.28M	915K	-147K	-208K	-538K	-84K	87K	314K	323K	87K	87K	86K	483K	482K	87K	145K	-185K	-117K	347K	285K	206K	122K	45K	27K	394K	792K	778K	778K	1.2M	1.59M
Deferred Income Tax	n/a	n/a	n/a	n/a	-490K	-490K	-490K	-490K	n/a	n/a	n/a	166K	166K	166K	166K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-376K	-778K	-778K	-778K	-1.2M	-1.59M
Change in Working Capital	2.63M	326K	4.93M	7.29M	3.25M	4.68M	2.59M	298K	2.92M	4.97M	1.93M	5.46M	5.35M	3.85M	5.88M	425K	1.89M	942K	36K	3.21M	323K	641K	-482K	-527K	-1.49M	-1.07M	-2.69M	-2.07M	-2.07M	-804K	254K	-88K	1.18M	2.54M	2.49M	1.79M	2.15M
Operating Cash Flow	-37.35M	-41.77M	-33.68M	-32.78M	-34.28M	-32.97M	-35.5M	-36.21M	-33.81M	-31.06M	-30.77M	-27.42M	-25.97M	-24.31M	-22.77M	-25.98M	-22.61M	-20.6M	-18.95M	-12.21M	-11.94M	-10.85M	-9.1M	-9.2M	-9.95M	-10.18M	-12.08M	-13.62M	-15.54M	-15.89M	-16.85M	-17.17M	-16.78M	-16.41M	-16.14M	-17.79M	-16.16M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	10M	20M	30M	30M	30M	30M	30M	30M	20M	10M	10M	20M	20M	20M	10M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	568K	845K	1.22M	651K	651K	374K	899K	899K	899K	899K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	-80K	-18K	-18K	n/a	n/a	n/a	-48K	-48K	-48K	-97K	-49K	-49K	-49K	-67K	-204K	-204K	-204K	-197K	-454K	-848K	-848K	-1.18M	-2.02M	-1.63M	-1.63M	-1.58M	-1.58M	-1.58M	-1.58M	-1.57M	-339K	-339K	-339K	-220K	-1.09M	-1.09M	-1.09M
Other Financial Acitivies	11.24M	11.24M	10.39M	10.41M	10.03M	10.03M	10.08M	48K	48K	48K	n/a	n/a	10M	10.07M	10.2M	10.2M	204K	197K	454K	454K	454K	789K	1.63M	1.63M	1.63M	1.58M	1.58M	1.58M	1.58M	1.57M	-1.16M	339K	339K	220K	2.59M	1.09M	1.09M
Financial Cash Flow	21.23M	31.23M	40.38M	40.41M	40.03M	40.03M	40.03M	30M	20M	10M	10M	20M	36.81M	36.81M	26.82M	16.82M	44K	263K	1.17M	934K	48.29M	50.08M	49.3M	50.74M	12.93M	15.38M	15.25M	14.99M	5.89M	3.58M	7.75M	8.3M	8.07M	5.92M	10.88M	9.43M	9.17M
Net Cash Flow	-16.12M	-10.54M	6.7M	7.63M	5.56M	7.07M	4.53M	-6.21M	-13.61M	-21.06M	-20.77M	-7.42M	10.85M	12.51M	4.04M	-9.17M	-22.57M	-20.34M	-17.78M	-11.28M	36.36M	39.23M	40.2M	41.55M	2.98M	5.2M	3.18M	1.37M	-9.66M	-12.31M	-9.1M	-8.88M	-8.71M	-10.48M	-5.26M	-8.36M	-6.99M
Free Cash Flow	-37.35M	-41.77M	-33.68M	-32.78M	-34.28M	-32.97M	-35.5M	-36.21M	-33.81M	-31.06M	-30.77M	-27.42M	-25.97M	-24.31M	-22.77M	-25.98M	-22.61M	-20.6M	-18.95M	-12.21M	-11.94M	-10.85M	-9.1M	-9.2M	-9.95M	-10.18M	-12.08M	-13.62M	-15.54M	-15.89M	-16.85M	-17.17M	-16.78M	-16.41M	-16.14M	-17.79M	-16.16M